This is not the latest version of this item. The latest version can be found here.
Continuous bioactivity-dependent evolution of an antibiotic biosynthetic pathway
Name
s41467-020-18018-2.pdf
Description
Published version
Size
685.3 KB
Format
Adobe PDF
Checksum (MD5)
5b92268b5fc2b7315be038084ddc84f8
Author(s) • •
Johnston, Chad W
Badran, Ahmed H
Collins, James J
Date Issued
2020
Journal
Nature Communications
Publisher
Springer Science and Business Media LLC
Version
Final published version
Abstract
© 2020, The Author(s). Antibiotic biosynthetic gene clusters (BGCs) produce bioactive metabolites that impart a fitness advantage to their producer, providing a mechanism for natural selection. This selection drives antibiotic evolution and adapts BGCs for expression in different organisms, potentially providing clues to improve heterologous expression of antibiotics. Here, we use phage-assisted continuous evolution (PACE) to achieve bioactivity-dependent adaptation of the BGC for the antibiotic bicyclomycin (BCM), facilitating improved production in a heterologous host. This proof-of-principle study demonstrates that features of natural bioactivity-dependent evolution can be engineered to access unforeseen routes of improving metabolic pathways and product yields.
Terms of Use
Creative Commons Attribution 4.0 International license
Persistent DSpace Link
DOI of Published Version
10.1038/S41467-020-18018-2